AIImpactLab
9 impact clustersWork & marketsCognition & learningTechnical failuresPrivacySecurityEnvironmentLaw & informationSocial good & healthSystemic risk
Search the evidence

Find the signal.

Search titles, impact clusters, countries, organizations and the full text of every analysis.

3 stories found

Law & informationGlobal+1 clusters01

Owens et al., “Patient Perspectives on AI-Drafted Electronic Portal Messages”

This Duke/NYU-linked qualitative study of 40 patients finds that patients value AI-drafted portal replies mainly for efficiency, but their acceptance is conditional on clinician review, accountability, and disclosure. Patients did not uniformly want “more empathy”; they wanted tone, length, and detail to match the stakes of the message, with lower-stakes refills treated differently from serious clinical concerns.

2 min
A patient reviews clear AI-prepared questions before meeting a surgeon, with an anxiety gauge and consultation timer both falling.
Social good & healthChina+4 clusters02

A local AI briefing cut pre-surgery anxiety and physician workload

A randomized phase II study offers a bounded example of medical AI that helped without pretending to replace the clinician. Researchers assigned 268 people newly diagnosed with prostate cancer and scheduled for radical prostatectomy to standard communication or an AI-assisted pathway. The intervention used a locally deployed large language model to prepare personalized answers to patient questions before the routine face-to-face discussion. Physicians remained responsible for the encounter and were blinded to group assignment. The AI-assisted group reported a mean post-communication GAD-7 anxiety score of 3.2, compared with 5.7 in the control group. Physician workload on the NASA-TLX scale averaged 39.9 versus 56.8, and routine communication time fell from 19.9 to 11.3 minutes. Satisfaction, emotions, and illness perceptions also improved. This is stronger evidence than a product testimonial, but it is not a general verdict on AI in medicine. The study was conducted at one cancer center, used a specific preoperative setting, measured near-term outcomes, and does not establish diagnostic accuracy, surgical outcomes, or long-term safety. The trial registry also still shows an earlier estimated enrollment of 160 and future completion dates, while the published paper reports 268 randomized participants; that record mismatch should be clarified. The design’s most important feature is the boundary: the model answered common questions in advance, responses were reviewed, and the surgeon still conducted the consent conversation. AI did not replace the relationship. It gave the relationship a better starting point.

10 min
A conventional microscope with a compact motorized stage scans a bone-marrow slide and routes candidate-cell evidence to a gloved clinical reviewer.
Social good & healthUnited States and Global+3 clusters03

A low-cost self-driving microscope screens bone marrow slides for acute leukemia

A Nature Communications study presents ALLocate, a low-cost AI-powered plugin that turns a conventional microscope into a self-driving screening system for acute leukemia. The system automatically selects useful bone-marrow regions, detects cells, and produces a slide-level result without a whole-slide scanner. Researchers trained and evaluated it with more than 11,000 annotated regions and 130,000 annotated cells, then used independent multi-institutional cohorts that included 165 physical bone-marrow smear slides. Reported performance exceeded 0.99 AUROC for region selection, reached 0.90 mean average precision for cell detection, and achieved 88 percent accuracy for diagnosis on glass slides. That combination could make automated screening more accessible where scanners and specialist expertise are scarce. It does not support an autonomous final diagnosis. An 88 percent result leaves clinically important errors, and the study does not erase the need for population-specific validation, slide-quality checks, calibration, human confirmation, and escalation to a pathologist. The strongest deployment is a lower-cost bridge to expertise, not a substitute for it.

5 min